You can also argue that it is chicken and egg, and we want the clinical trials to be conducted (EMD AML with current formulation and the rest with new formulation starting in Q3 2023) before doing the marketing or you may give away a chunk of shares for lower valuation. If so, just tell me in the face that we are delayed by another 12 months on marketing if that is the case.
Ann: Race 2022 AGM Presentations, page-7
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
0.010(0.57%) |
Mkt cap ! $298.0M | |||
| Open | High | Low | Value | Volume |
| $1.73 | $1.83 | $1.73 | $272.0K | 152.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9998 | $1.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |